RecruitingNCT06953245
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
Sponsor
Mayo Clinic
Enrollment
20 participants
Start Date
Apr 30, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates patient-reported experiences of radiation dermatitis in patients with breast cancer undergoing radiotherapy.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Adults ≥ 18
- Patients diagnosed with breast cancer
- Currently undergoing or recently completed radiotherapy
- Willing to provide verbal/oral consent
Exclusion Criteria3
- Persons \< 18
- Inability to provide verbal consent
- Non-English speakers (unless translations are available)
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06953245
Related Trials
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT06418204467 locations
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT059415204 locations
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
NCT0618475011 locations
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
NCT061953063 locations